NIH Seeks Input on Clinical Trials Database Refresh
Published Date: 3/27/2026
Notice
Summary
The National Cancer Institute wants your thoughts on updating the Clinical Trials Reporting Program (CTRP) database, which tracks cancer research studies. If you’re involved in clinical trials or just curious, now’s the time to speak up before April 27, 2026. This update won’t cost you money but helps keep cancer research info clear and up-to-date!
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
CTRP reporting creates time burden
If you are a clinical research administrator registering NCI-supported trials, you must use the CTRP system to submit initial registrations, registration updates, amendments, and accrual updates. The collection requests OMB approval for three years, estimates 18,000 annualized burden hours across respondents, and states there are no costs to respondents other than their time (OMB control expiration 02/28/2026).
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
Previous / Next Documents
Previous: 2026-05936 — Data Collection Available for Public Comments
The Small Business Administration (SBA) is asking for your thoughts on how it collects info from small business investment companies. This helps make sure these companies follow the rules, and you have 30 days to share your comments before April 27, 2026. About 323 companies are involved, and the process won’t cost extra money but takes some time to complete.
Next: 2026-05938 — Proposed Information Collection Activity; Temporary Assistance for Needy Families (TANF) Pilot Evaluation
The government wants to test new ways to help families get Temporary Assistance for Needy Families (TANF) by picking up to five states for a special pilot program. They’ll collect info from staff and participants to see what works best and share results with Congress by 2027. If you work with TANF or live in a pilot state, you might see some new surveys and interviews starting soon!
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in